190 related articles for article (PubMed ID: 12020261)
1. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease.
Hogervorst E; Ribeiro HM; Molyneux A; Budge M; Smith AD
Arch Neurol; 2002 May; 59(5):787-93. PubMed ID: 12020261
[TBL] [Abstract][Full Text] [Related]
2. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
Clarke R; Smith AD; Jobst KA; Refsum H; Sutton L; Ueland PM
Arch Neurol; 1998 Nov; 55(11):1449-55. PubMed ID: 9823829
[TBL] [Abstract][Full Text] [Related]
3. Impacts of hyper-homocysteinemia and white matter hyper-intensity in Alzheimer's disease patients with normal creatinine: an MRI-based study with longitudinal follow-up.
Huang CW; Chang WN; Lui CC; Chen CF; Lu CH; Wang YL; Chen C; Juang YY; Lin YT; Tu MC; Chang CC
Curr Alzheimer Res; 2010 Sep; 7(6):527-33. PubMed ID: 20455861
[TBL] [Abstract][Full Text] [Related]
4. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
[TBL] [Abstract][Full Text] [Related]
5. Plasma homocysteine and severe white matter disease.
Censori B; Partziguian T; Manara O; Poloni M
Neurol Sci; 2007 Oct; 28(5):259-63. PubMed ID: 17972040
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men.
Sachdev P; Parslow R; Salonikas C; Lux O; Wen W; Kumar R; Naidoo D; Christensen H; Jorm A
Arch Neurol; 2004 Sep; 61(9):1369-76. PubMed ID: 15364682
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study.
Hooshmand B; Solomon A; Kåreholt I; Leiviskä J; Rusanen M; Ahtiluoto S; Winblad B; Laatikainen T; Soininen H; Kivipelto M
Neurology; 2010 Oct; 75(16):1408-14. PubMed ID: 20956786
[TBL] [Abstract][Full Text] [Related]
8. Plasma Total Homocysteine Levels are not Associated with Medial Temporal Lobe Atrophy, but with White Matter Changes in Alzheimer's Disease.
Kim SR; Choi SH; Ha CK; Park SG; Pyun HW; Yoon DH
J Clin Neurol; 2009 Jun; 5(2):85-90. PubMed ID: 19587815
[TBL] [Abstract][Full Text] [Related]
9. Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging.
Mizrahi EH; Jacobsen DW; Debanne SM; Traore F; Lerner AJ; Friedland RP; Petot GJ
J Nutr Health Aging; 2003; 7(3):160-5. PubMed ID: 12766793
[TBL] [Abstract][Full Text] [Related]
10. Impact of homocysteine on cortical perfusion and cognitive decline in mild Alzheimer's dementia.
Huang CW; Chang WN; Huang SH; Lui CC; Chen NC; Chang YT; Lee CC; Chang CC; Chang AY
Eur J Neurol; 2013 Aug; 20(8):1191-7. PubMed ID: 23581395
[TBL] [Abstract][Full Text] [Related]
11. Plasma total homocysteine levels are associated with advanced leukoaraiosis but not with asymptomatic microbleeds on T2*-weighted MRI in patients with stroke.
Naka H; Nomura E; Takahashi T; Wakabayashi S; Kajikawa H; Kohriyama T; Mimori Y; Matsumoto M
Eur J Neurol; 2006 Mar; 13(3):261-5. PubMed ID: 16618343
[TBL] [Abstract][Full Text] [Related]
12. Medial temporal lobe atrophy, apolipoprotein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer's disease.
de Silva HA; Gunatilake SB; Johnston C; Warden D; Smith AD
Exp Aging Res; 2005; 31(3):345-54. PubMed ID: 16036726
[TBL] [Abstract][Full Text] [Related]
13. Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel.
Mizrahi EH; Bowirrat A; Jacobsen DW; Korczyn AD; Traore F; Petot GJ; Lerner AJ; Debanne SM; Adunsky A; Dibello PM; Friedland RP
J Neurol Sci; 2004 Dec; 227(1):109-13. PubMed ID: 15546600
[TBL] [Abstract][Full Text] [Related]
14. Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study.
Hooshmand B; Polvikoski T; Kivipelto M; Tanskanen M; Myllykangas L; Erkinjuntti T; Mäkelä M; Oinas M; Paetau A; Scheltens P; van Straaten EC; Sulkava R; Solomon A
Brain; 2013 Sep; 136(Pt 9):2707-16. PubMed ID: 23983028
[TBL] [Abstract][Full Text] [Related]
15. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease.
Irizarry MC; Gurol ME; Raju S; Diaz-Arrastia R; Locascio JJ; Tennis M; Hyman BT; Growdon JH; Greenberg SM; Bottiglieri T
Neurology; 2005 Nov; 65(9):1402-8. PubMed ID: 16275827
[TBL] [Abstract][Full Text] [Related]
16. Cerebral white matter changes (leukoaraiosis), stroke, and gait disturbance.
Briley DP; Wasay M; Sergent S; Thomas S
J Am Geriatr Soc; 1997 Dec; 45(12):1434-8. PubMed ID: 9400551
[TBL] [Abstract][Full Text] [Related]
17. Relation between plasma homocysteine and Alzheimer's disease.
Nilsson K; Gustafson L; Hultberg B
Dement Geriatr Cogn Disord; 2002; 14(1):7-12. PubMed ID: 12053126
[TBL] [Abstract][Full Text] [Related]
18. Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors.
Miwa K; Tanaka M; Okazaki S; Yagita Y; Sakaguchi M; Mochizuki H; Kitagawa K
J Alzheimers Dis; 2016; 49(2):503-13. PubMed ID: 26484913
[TBL] [Abstract][Full Text] [Related]
19. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study.
Nygård O; Vollset SE; Refsum H; Stensvold I; Tverdal A; Nordrehaug JE; Ueland M; Kvåle G
JAMA; 1995 Nov; 274(19):1526-33. PubMed ID: 7474221
[TBL] [Abstract][Full Text] [Related]
20. The role of homocysteine as a significant risk factor for white matter lesions in Japanese women with rheumatoid arthritis.
Anan F; Masaki T; Tatsukawa H; Nagano S; Oribe M; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2009 Jan; 58(1):69-73. PubMed ID: 19059533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
